WallStreetZen

NYSE: LLY
ELI LILLY & Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LLY

Based on 11 analysts offering 12 month price targets for ELI LILLY & Co.
Min Forecast
$144.00-30.14%
Avg Forecast
$187.91-8.84%
Max Forecast
$225.00+9.15%

Should I buy or sell LLY stock?

Strong Buy
Strong Buy
9 analysts 75%
Buy
0 analysts 0%
Hold
3 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is LLY forecast to generate an efficient return?
Company
235.8%
Industry
75.54%
Market
61.82%
LLY's Return on Equity is forecast to be high in 4 years (235.8%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is LLY forecast to generate an efficient return on assets?
Company
25.9%
Industry
16.98%
Market
19.68%
LLY is forecast to generate higher Return on Assets (25.9%) than the US Drug Manufacturers - General industry average (16.98%)
Forecast

LLY earnings per share forecast

What is LLY's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$8.08+31.45%
Avg 2 year Forecast
$8.71+41.63%
Avg 3 year Forecast
$10.34+68.13%
LLY's earnings are forecast to grow at a rate of 17.08% per year, which is not exceptional
Forecast

LLY revenue forecast

What is LLY's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$27.5B+18.27%
Avg 2 year Forecast
$28.1B+21.1%
Avg 3 year Forecast
$30.1B+29.78%
LLY's revenue is forecast to grow at a rate of 8.46% per year, which is not exceptional
Forecast

LLY earnings growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.08%
Industry
25.04%
Market
20.34%
LLY's earnings are forecast to grow slower (17.08% per year) than the US Drug Manufacturers - General industry average (25.04%)
Forecast
LLY's earnings are forecast to grow slower (17.08% per year) than the US market average (20.34%)
Forecast
LLY's earnings are forecast to grow faster (17.08% per year) than the risk-free savings rate (1.1%)
Forecast

LLY revenue growth forecast

How is LLY forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
8.46%
Industry
6.45%
Market
14.82%
LLY's revenues are forecast to grow faster (8.46% per year) than the US Drug Manufacturers - General industry average (6.45%)
Forecast
LLY's revenues are forecast to grow slower (8.46% per year) than the US market average (14.82%)
Forecast

ELI LILLY & Stock Forecast FAQ

Is ELI LILLY & Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: LLY) stock is to Strong Buy LLY stock.

Out of 12 analysts, 9 (75%) are recommending LLY as a Strong Buy, 0 (0%) are recommending LLY as a Buy, 3 (25%) are recommending LLY as a Hold, 0 (0%) are recommending LLY as a Sell, and 0 (0%) are recommending LLY as a Strong Sell.

What is LLY's Price Target?

According to 11 Wall Street analysts that have issued a 1 year LLY price target, the average LLY price target is $187.91, with the highest LLY stock price forecast at $225.00 and the lowest LLY stock price forecast at $144.00.

On average, Wall Street analysts predict that ELI LILLY &'s share price could fall to $187.91 by Jan 22, 2022. The average ELI LILLY & stock price prediction forecasts a potential downside of 8.84% from the current LLY share price of $206.14.

What is LLY's earnings growth forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s forecast annual earnings growth rate of 17.08% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 25.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.34%.

ELI LILLY &'s earnings in 2020 is $5,572,600,000.On average, 7 Wall Street analysts forecast LLY's earnings for 2021 to be $7,732,393,428, with the lowest LLY earnings forecast at $7,412,645,383, and the highest LLY earnings forecast at $7,986,527,606. On average, 4 Wall Street analysts forecast LLY's earnings for 2022 to be $8,330,856,940, with the lowest LLY earnings forecast at $7,795,233,532, and the highest LLY earnings forecast at $8,675,186,274.

In 2023, LLY is forecast to generate $9,889,903,646 in earnings, with the lowest earnings forecast at $9,889,903,646 and the highest earnings forecast at $9,889,903,646.

What is LLY's revenue growth forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s forecast annual revenue growth rate of 8.46% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.82%.

ELI LILLY &'s revenue in 2020 is $23,213,800,000.On average, 3 Wall Street analysts forecast LLY's revenue for 2021 to be $26,259,230,272,822, with the lowest LLY revenue forecast at $26,069,393,859,269, and the highest LLY revenue forecast at $26,409,103,441,292. On average, 3 Wall Street analysts forecast LLY's revenue for 2022 to be $26,887,239,154,373, with the lowest LLY revenue forecast at $26,792,648,060,464, and the highest LLY revenue forecast at $27,036,595,828,843.

In 2023, LLY is forecast to generate $28,816,539,367,616 in revenue, with the lowest revenue forecast at $28,816,539,367,616 and the highest revenue forecast at $28,816,539,367,616.

What is LLY's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: LLY) ELI LILLY &'s current Earnings Per Share (EPS) is $6.15. On average, analysts forecast that LLY's EPS will be $8.08 for 2021, with the lowest EPS forecast at $7.75, and the highest EPS forecast at $8.35. On average, analysts forecast that LLY's EPS will be $8.71 for 2022, with the lowest EPS forecast at $8.15, and the highest EPS forecast at $9.07. In 2023, LLY's EPS is forecast to hit $10.34 (min: $10.34, max: $10.34).

What is LLY's forecast return on equity (ROE) for 2021-2024?

(NYSE: LLY) forecast ROE is 235.8%, which is considered strong.

What is LLY's forecast return on assets (ROA) for 2021-2024?

(NYSE: LLY) forecast ROA is 25.9%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.98%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics